We are live on ! Find out more
NGNE icon

Neurogene
NGNE

35 hedge funds and large institutions have $138M invested in Neurogene in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 9

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 39 → 35 (-4)

19% less capital invested

Capital invested by funds: $171M → $138M (-$33.3M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
35
Holders Change
-4
Holders Change %
-10.26%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
19
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$9.77M
2
Goldman Sachs
Goldman Sachs
New York
+$9.26M
3
BA
BlackRock Advisors
Delaware
+$866K
4
Franklin Resources
Franklin Resources
California
+$851K
5
RA
Royce & Associates
New York
+$754K

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$2.32M
2
VAM
Visium Asset Management
New York
-$956K
3
SM
Sabby Management
Florida
-$753K
4
Marshall Wace
Marshall Wace
United Kingdom
-$506K
5
IHM
Iguana Healthcare Management
New York
-$312K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$118K – – –
ProShare Advisors
27
ProShare Advisors
Maryland
$112K -$11.7K -60 -9%
BCM
28
Bridgeway Capital Management
Texas
$106K -$29.2K -150 -20%
TRCT
29
Tower Research Capital (TRC)
New York
$21K +$23.9K +123 New
Citigroup
30
Citigroup
New York
$19K -$1.75K -9 -8%
JP Morgan Chase
31
JP Morgan Chase
New York
$15K +$16.5K +85 New
DADC
32
D.A. Davidson & Co
Montana
$8K +$9.72K +50 New
LTFS
33
Ladenburg Thalmann Financial Services
Florida
$4K +$4.86K +25 New
Barclays
34
Barclays
United Kingdom
$1K -$1.55K -8 -57%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$555 +$109K +563 +22%
NI
36
Numeric Investors
Massachusetts
– -$2.32M -9,291 Closed
SM
37
Sabby Management
Florida
– -$753K -3,016 Closed
Marshall Wace
38
Marshall Wace
United Kingdom
– -$506K -2,027 Closed
IHM
39
Iguana Healthcare Management
New York
– -$312K -1,250 Closed
PAM
40
Panagora Asset Management
Massachusetts
– -$50K -200 Closed
Bank of America
41
Bank of America
North Carolina
– -$36K -144 Closed
UBS Group
42
UBS Group
Switzerland
– -$13K -50 Closed
1
2

NGNE Hedge Fund Activity: Q1 2016 in Review

35 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2016, worth a combined $138M — down 19% from $171M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NGNE and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 19 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $9.77M. The largest seller was Numeric Investors, exiting entirely with an estimated $2.32M sold.

  • 35 institutional investors held Neurogene (NGNE) as of Q1 2016, down from 39 in Q4 2015.
  • Funds reported $138M of Neurogene stock for Q1 2016, down 19% quarter-over-quarter.
  • 4 funds opened new Neurogene positions in Q1 2016 and 7 closed out, a net change of -3 holders.
  • The largest Neurogene buyer in Q1 2016 was Baker Bros. Advisors, an estimated $9.77M added.
  • The largest Neurogene seller in Q1 2016 was Numeric Investors, an estimated $2.32M sold.

Based on aggregated 13F filings for Q1 2016.